NCT07096284 The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock
| NCT ID | NCT07096284 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Avicenna Military Hospital |
| Condition | Septic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-01-05 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-01-05 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ratio of the venous-arterial carbon dioxide partial pressure difference to the arteriovenous oxygen content difference (Pv-aCO₂/Ca-vO₂) may be a marker of anaerobic metabolism in patients with acute circulatory failure. This study aims to assess the prognostic value of the PvCO2-PaCO2/CaO2-CvO2 in the early phase of septic shock.
Eligibility Criteria
Inclusion Criteria: Patients aged over 18 years presenting with septic shock, defined as sepsis with persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) ≥ 65 mmHg and lactatemia \> 2 mmol/L despite adequate fluid resuscitation. Sepsis is defined by the presence of a suspected or confirmed infectious source associated with organ dysfunction (neurological, respiratory, renal, hepatic, or hematological). \[Sepsis 3 criteria\] Exclusion Criteria: * Absence of central venous access. * Central venous access not positioned in the superior vena cava (e.g., femoral access).
Contact & Investigator
Younes Aissaoui Pr
PRINCIPAL INVESTIGATOR
Cadi Ayyad University. Faculty of Medicine and Pharmacy. Avicenna Military Hospital.
Frequently Asked Questions
Who can join the NCT07096284 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Septic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07096284 currently recruiting?
Yes, NCT07096284 is actively recruiting participants. Contact the research team at younes.aissaoui@uca.ma for enrollment information.
Where is the NCT07096284 trial being conducted?
This trial is being conducted at Marrakesh, Morocco, Marrakesh, Morocco, Marrakesh, Morocco.
Who is sponsoring the NCT07096284 clinical trial?
NCT07096284 is sponsored by Avicenna Military Hospital. The principal investigator is Younes Aissaoui Pr at Cadi Ayyad University. Faculty of Medicine and Pharmacy. Avicenna Military Hospital.. The trial plans to enroll 30 participants.